VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2012

Nov 20, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2012-11-16

Reporting Person: Sachdev Amit (SVP, Corp Affairs & Pub Policy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-11-16	Common Stock	S	2287	$41.29	Disposed	18821	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	772	Indirect

Footnotes

F1: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.

F2: Open market sales reported on this line occurred at a weighted average price of $41.29 (range $41.04 to $41.82).

F3: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.